U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275970) titled 'Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD' on Nov. 26.

Brief Summary: This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: PTSD

Intervention: DRUG: Psychedelic

Organic Whole Psilocybin-Containing Mushrooms

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sue Sisley

Information provided b...